These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22723462)

  • 21. Inhibition of proliferation and migration of tumor cells through phenylboronic acid-functionalized polyamidoamine-mediated delivery of a therapeutic DNAzyme Dz13.
    Yang J; Zhang J; Xing J; Shi Z; Han H; Li Q
    Int J Nanomedicine; 2019; 14():6371-6385. PubMed ID: 31496692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
    Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity.
    Dass CR; Friedhuber AM; Khachigian LM; Dunstan DE; Choong PF
    J Microencapsul; 2008 Sep; 25(6):421-5. PubMed ID: 18465314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-jun: pharmaceutical target for DNAzyme therapy of multiple pathologies.
    Dass CR; Choong PF
    Pharmazie; 2008 Jun; 63(6):411-4. PubMed ID: 18604982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.
    Sjöblom T; Shimizu A; O'Brien KP; Pietras K; Dal Cin P; Buchdunger E; Dumanski JP; Ostman A; Heldin CH
    Cancer Res; 2001 Aug; 61(15):5778-83. PubMed ID: 11479215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced retinal microvascular density, improved forepaw reach, comparative microarray and gene set enrichment analysis with c-jun targeting DNA enzyme.
    Chan CW; Kaplan W; Parish CR; Khachigian LM
    PLoS One; 2012; 7(7):e39160. PubMed ID: 22815700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific repression of mutant K-RAS by 10-23 DNAzyme: sensitizing cancer cell to anti-cancer therapies.
    Yu SH; Wang TH; Au LC
    Biochem Biophys Res Commun; 2009 Jan; 378(2):230-4. PubMed ID: 19014906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
    Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
    Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.
    Tortora G; Caputo R; Damiano V; Bianco R; Fontanini G; Cuccato S; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2001 Aug; 7(8):2537-44. PubMed ID: 11489837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of c-jun in human liposarcoma growth: supporting data from clinical immunohistochemistry and DNAzyme efficacy.
    Dass CR; Galloway SJ; Clark JC; Khachigian LM; Choong PF
    Cancer Biol Ther; 2008 Aug; 7(8):1297-301. PubMed ID: 18497564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model.
    Cooper SJ; MacGowan J; Ranger-Moore J; Young MR; Colburn NH; Bowden GT
    Mol Cancer Res; 2003 Sep; 1(11):848-54. PubMed ID: 14517347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors.
    Papassava P; Gorgoulis VG; Papaevangeliou D; Vlahopoulos S; van Dam H; Zoumpourlis V
    Cancer Res; 2004 Dec; 64(23):8573-84. PubMed ID: 15574764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
    Dosch J; Kaina B
    Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice.
    Rafferty P; Egenolf D; Brosnan K; Makropoulos D; Jordan J; Meshaw K; Walker M; Volk A; Bugelski PJ
    J Immunotoxicol; 2012; 9(1):43-55. PubMed ID: 22299716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest.
    Yu W; Sanders BG; Kline K
    Nutr Cancer; 1997; 27(1):92-101. PubMed ID: 8970189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells.
    Tormos C; Javier Chaves F; Garcia MJ; Garrido F; Jover R; O'Connor JE; Iradi A; Oltra A; Oliva MR; Sáez GT
    Cancer Lett; 2004 May; 208(1):103-13. PubMed ID: 15105052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth.
    Deng R; Yang F; Chang SH; Tang J; Qin J; Feng GK; Ding K; Zhu XF
    Mol Pharmacol; 2012 Aug; 82(2):189-98. PubMed ID: 22553359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A potential synergistic anticancer effect of paclitaxel and amifostine on endometrial cancer.
    Dai D; Holmes AM; Nguyen T; Davies S; Theele DP; Verschraegen C; Leslie KK
    Cancer Res; 2005 Oct; 65(20):9517-24. PubMed ID: 16230417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
    Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.